Plasma Renin Activity in Distinct Patient Populations with Heart Failure and Reduced Ejection Fraction

被引：1
|
作者：
Nijst, Petra [1 ]
Verbrugge, Frederik H. [1 ]
Martens, Pieter [1 ]
Bertrand, Philippe B. [1 ]
Dupont, Matthias [1 ]
Francis, Gary S. [2 ]
Tang, W. H. Wilson [3 ]
Mullens, Wilfried [1 ]
机构：
[1] Ziekenhuis Oost Limburg UHasselt, Genk, Belgium
[2] Univ Minnesota Hlth Heart Care, Minneapolis, MN USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
来源：
JOURNAL OF CARDIAC FAILURE | 2016年 / 22卷 / 08期
关键词：
D O I：
10.1016/j.cardfail.2016.06.099
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
082
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [41] Vericiguat in Heart Failure with a Reduced Ejection Fraction: Patient Selection and Special Considerations
    Kassis-George, Hayah
    Verlinden, Nathan J.
    Fu, Sheng
    Kanwar, Manreet
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 315 - 322
  • [42] Plasma proteomic profile predicts survival in heart failure with reduced ejection fraction
    Gui, H.
    She, R. C.
    Li, J.
    Sabbah, H.
    Williams, L. K.
    Lanfear, D.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3939 - 3939
  • [43] Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
    Muhammad Nauman Khan
    Najia Aslam Soomro
    Khalid Naseeb
    Usman Hanif Bhatti
    Rubina Rauf
    Iram Jehan Balouch
    Ali Moazzam
    Sonia Bashir
    Tariq Ashraf
    Musa Karim
    BMC Cardiovascular Disorders, 23
  • [44] Efficacy and Safety of Ivabradine in an Elderly Patient with Heart Failure with Reduced Ejection Fraction
    Shunsuke Kiuchi
    Shinji Hisatake
    Takayuki Kabuki
    Takashi Oka
    Takahiro Fujii
    Shintaro Dobashi
    Takahide Sano
    Takanori Ikeda
    Clinical Drug Investigation, 2021, 41 : 193 - 196
  • [45] Efficacy and Safety of Ivabradine in an Elderly Patient with Heart Failure with Reduced Ejection Fraction
    Kiuchi, Shunsuke
    Hisatake, Shinji
    Kabuki, Takayuki
    Oka, Takashi
    Fujii, Takahiro
    Dobashi, Shintaro
    Sano, Takahide
    Ikeda, Takanori
    CLINICAL DRUG INVESTIGATION, 2021, 41 (02) : 193 - 196
  • [46] Curative effect analysis of urapidil on heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
    Yuan, Xiao-Ye
    Ding, Cun-Tao
    Li, Jing
    Tan, Jing
    Wang, Yan-Ling
    Fan, Zhen-Xing
    He, Jing-Yu
    Yang, Wei
    Hua, Qi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 494 - 503
  • [47] Pressure-volume Profiles In Heart Failure With Reduced Ejection Fraction And Heart Failure With Preserved Ejection Fraction
    Kittipibul, Veraprapas
    Yaranov, Dmitry
    Rao, Vishal
    Jefferies, John
    Silver, Marc A.
    Fudim, Marat
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 603 - 603
  • [48] Complex Energy Metabolic Changes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction
    De Jong, Kirstie A.
    Lopaschuk, Gary D.
    CANADIAN JOURNAL OF CARDIOLOGY, 2017, 33 (07) : 860 - 871
  • [49] DOES HEART FAILURE WITH PRESERVED EJECTION FRACTION HAVE A DIFFERENT PROGNOSIS THAT HEART FAILURE WITH REDUCED EJECTION FRACTION?
    Ouzan, James M.
    Shani, Michal
    Keren, Andre
    Gotsman, Israel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 725 - 725
  • [50] Heart Failure Preserved Ejection Fraction Patients Benefit From Heart Failure Reduced Ejection Fraction Guidelines
    Steahr, Gregg
    Kelly, Linda
    Moore, Meredith
    Hott, Brenda
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S73 - S74
12345